carboplatin,durvalumab,paclitaxel,olaparib,bevacizumab
astrazeneca,merck,roche
['duo-o', 'gyn', 'ovarian']
philipp harter: results from the randomized, placebo (pbo)-controlled phase iii duo-o trial.
#asco #gyncsm #ovariancancer 
18-year Ovarian Cancer Survivor/Research Advocate. 2 recurrences, now 15 years NED. Loves laughter theater puzzles F1 & PoGO. Evidence based medicine=HOPE